Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo
about
Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancerStudy of the UTMD-based delivery system to induce cervical cancer cell apoptosis and inhibit proliferation with shRNA targeting Survivin.Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients.Zebrafish models of p53 functions.Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.Rb1 loss modifies but does not initiate alveolar rhabdomyosarcomaRNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoDissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.The therapeutic potential of RNA interference.Adult human sarcomas. II. Medical oncology.Molecular and cellular biology of rhabdomyosarcoma.Effects of RAS on the genesis of embryonal rhabdomyosarcoma.On-chip selective capture of cancer cells and ultrasensitive fluorescence detection of survivin mRNA in a single living cell.Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.Synergistic Antitumour Properties of viscumTT in Alveolar RhabdomyosarcomaOptimization and apoptosis induction by RNAi with UTMD technology in vitro.Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells.Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.MYCN and survivin cooperatively contribute to malignant transformation of fibroblasts.Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin.
P2860
Q28306223-E4EACCA8-4116-492B-96B4-C6E04A5FA24EQ30457441-CC4A876F-4C85-4D04-AE75-2AF69EF2AF88Q33514778-A3F6E0B7-6495-4296-9F4D-8D5FC7BA95E0Q33533999-472EC4E2-E677-4763-9117-83C37CD8071CQ34014685-7F7E1D4C-4A26-4D5A-A81B-4E31597DBE30Q34162514-9D82F698-46C4-4AE9-9312-AC7C893205B4Q34255856-665A9283-13B3-4F84-B57B-6292DBB933F5Q35225270-2ECC0A82-CE3C-4E43-984D-9326D81CE6B6Q35628857-415A864A-D7D3-46DF-8B94-2CB1A427768AQ36237868-32D20304-9189-46F4-8355-3C6B88B2DCBDQ36731430-3FE73F92-C639-484E-8BE0-ABF3B1A94ECAQ37630588-4635B431-3D4E-436C-BB6B-5BFFCD61EF2FQ38301662-2817A568-F54C-4739-9B28-6906A78D92BFQ38313665-6AD40243-5F00-4057-8999-F9BF78C296F6Q38853955-A477879A-B90E-4861-8D93-B6F28FCA53C7Q38856274-5139C78B-35E6-47D0-B72F-B3BACEEA19FDQ41169341-32CBA690-90EA-4689-83B5-B0D6F917CBF9Q42225268-AC74A3EC-5A03-4643-BF75-7EE9E1F453E2Q42947899-5B849C15-7051-4E4C-8A5F-1BE0614A9D8FQ47112233-A28630D8-A01F-4BA8-9840-0FC3E4216112Q47733296-02154287-D3CB-4E93-B76D-FBE1FDF63BADQ54239289-5F4C4D55-965A-4E0B-AA4F-8C5A3A7EC122Q54540314-A839369E-7F47-4E6E-AFF7-890CCA6EBCFA
P2860
Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Survivin-directed RNA interfer ...... essor of tumour growth in vivo
@en
type
label
Survivin-directed RNA interfer ...... essor of tumour growth in vivo
@en
prefLabel
Survivin-directed RNA interfer ...... essor of tumour growth in vivo
@en
P2093
P2860
P356
P1476
Survivin-directed RNA interfer ...... essor of tumour growth in vivo
@en
P2093
M P Holloway
R A Altura
S J Qualman
P2860
P304
P356
10.1136/JMG.2005.034686
P407
P577
2005-05-20T00:00:00Z